Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Identification of a novel selective H1-antihistamine with optimized pharmacokinetic properties for clinical evaluation in the treatment of insomnia.

Moree WJ, Li BF, Zamani-Kord S, Yu J, Coon T, Huang C, Marinkovic D, Tucci FC, Malany S, Bradbury MJ, Hernandez LM, Wen J, Wang H, Hoare SR, Petroski RE, Jalali K, Yang C, Sacaan A, Madan A, Crowe PD, Beaton G.

Bioorg Med Chem Lett. 2010 Oct 1;20(19):5874-8. doi: 10.1016/j.bmcl.2010.07.117. Epub 2010 Aug 3.

PMID:
20800486
2.

The expanding role of H1 antihistamines: a patent survey of selective and dual activity compounds 2005-2010.

Beaton G, Moree WJ.

Expert Opin Ther Pat. 2010 Sep;20(9):1197-218. doi: 10.1517/13543776.2010.510516. Review.

PMID:
20716024
4.

Review of the histamine system and the clinical effects of H1 antagonists: basis for a new model for understanding the effects of insomnia medications.

Krystal AD, Richelson E, Roth T.

Sleep Med Rev. 2013 Aug;17(4):263-72. doi: 10.1016/j.smrv.2012.08.001. Epub 2013 Jan 26. Review.

PMID:
23357028
5.

Ramelteon for the treatment of insomnia.

Borja NL, Daniel KL.

Clin Ther. 2006 Oct;28(10):1540-55. Review.

PMID:
17157111
7.
8.

Ramelteon (rozerem) a novel approach for insomnia treatment.

Laustsen G, Andersen M.

Nurse Pract. 2006 Apr;31(4):52-5. Review. No abstract available.

PMID:
16607213
9.

[H1-antihistaminics of the first generation].

Bennack E, Holzgrabe U.

Pharm Unserer Zeit. 2007;36(3):202-4. Review. German. No abstract available.

PMID:
17555056
10.

Antiallergic effects of H1-receptor antagonists.

Baroody FM, Naclerio RM.

Allergy. 2000;55 Suppl 64:17-27. Review.

11.

Ramelteon.

McGechan A, Wellington K.

CNS Drugs. 2005;19(12):1057-65; discussion 1066-7. Review.

PMID:
16332146
12.

[Mutagenesis of the human histamine H1 receptor and design of new antihistamine agents].

Differding E, Gillard M, Moguilevsky N, Varsalona F, Noyer M, Daliers J, Goldstein S, Neuwels M, Lassoie MA, Guillaume JP, Bascour M, Bollen A, Hénichart JP.

J Pharm Belg. 1996 May-Jun;51(3):155-60. Review. French.

PMID:
8778348
13.

Drug Insight: the use of melatonergic agonists for the treatment of insomnia-focus on ramelteon.

Pandi-Perumal SR, Srinivasan V, Poeggeler B, Hardeland R, Cardinali DP.

Nat Clin Pract Neurol. 2007 Apr;3(4):221-8. Review.

PMID:
17410109
14.

Ramelteon: a novel approach in the treatment of insomnia.

Reynoldson JN, Elliott E Sr, Nelson LA.

Ann Pharmacother. 2008 Sep;42(9):1262-71. doi: 10.1345/aph.1K676. Epub 2008 Jul 23. Review.

PMID:
18648020
15.

Molecular properties and signalling pathways of the histamine H1 receptor.

Smit MJ, Hoffmann M, Timmerman H, Leurs R.

Clin Exp Allergy. 1999 Jul;29 Suppl 3:19-28. Review.

PMID:
10444208
16.

[Development, structures, and new trends. H1-antihistamines].

Stark H, Schubert-Zsilavecz M.

Pharm Unserer Zeit. 2004;33(2):92-8. Review. German. No abstract available.

PMID:
15083617
17.

Reversible and irreversible labelling of H1- and H2 -receptors using novel [125I] probes.

Ruat M, Traiffort E, Bouthenet ML, Souil E, Pollard H, Moreau J, Schwartz JC, Martinez-Mir I, Palacios JM, Hirschfeld J, et al.

Agents Actions Suppl. 1991;33:123-44. Review.

PMID:
1675831
18.

Pharmacotherapy of insomnia.

Bhat A, Shafi F, El Solh AA.

Expert Opin Pharmacother. 2008 Feb;9(3):351-62. doi: 10.1517/14656566.9.3.351 . Review.

PMID:
18220487
19.

Ramelteon: a review of its use in insomnia.

Simpson D, Curran MP.

Drugs. 2008;68(13):1901-19. Review.

PMID:
18729542
20.

Drug interactions with newer antidepressants: role of human cytochromes P450.

Greenblatt DJ, von Moltke LL, Harmatz JS, Shader RI.

J Clin Psychiatry. 1998;59 Suppl 15:19-27. Review.

Supplemental Content

Support Center